E coli bioconjugate vaccine (GSK/Janssen)

N/A

Report date: 2024/12/06 20:00:46

Base Information

Drug NameE coli bioconjugate vaccine (GSK/Janssen)

Drug Alias NameExtra-intestinal pathogenic Escherichia coli vaccineExpec 4v ConjugateExPEC vaccineExPEC4VJNJ-860/EcoXyn-4V +[6]

ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsEscherichia coli Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgiumUnited StatesNetherlands +[6]

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Plc Johnson & Johnson Innovative Medicine

China Registration ClassN/A

Develop Information

Active CompaniesJanssen Research & Development Llc

Inactive CompaniesJanssen Pharmaceutical Kk

Active IndicationsEscherichia coli Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A